Jul 8, 2026 08:01AM
Jul 8, 2026 08:01AM
Jul 1, 2026 08:02AM
Jul 1, 2026 08:02AM
Jun 11, 2026 08:03AM
Jun 11, 2026 08:03AM
May 26, 2026 08:03AM 60 Degrees Pharmaceuticals enrolls first patient in tafenoquine babesiosis trial
May 26, 2026 08:02AM
May 15, 2026 08:42AM
Apr 15, 2026 08:04AM
Apr 15, 2026 08:02AM
Mar 31, 2026 07:01AM
Mar 18, 2026 08:02AM
Mar 18, 2026 08:01AM 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
Mar 11, 2026 07:24AM
Mar 11, 2026 07:24AM
Feb 2, 2026 08:03AM
Feb 2, 2026 08:01AM
Jan 28, 2026 08:02AM
Jan 28, 2026 08:01AM
Jan 22, 2026 08:03AM 60 Degrees Pharmaceuticals partners with Runway Health for malaria drug
Jan 22, 2026 08:01AM
Jan 15, 2026 08:01AM
Jan 15, 2026 08:01AM
Dec 29, 2025 08:02AM
Dec 29, 2025 08:01AM
Dec 11, 2025 08:02AM
Dec 11, 2025 08:01AM 60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026
Nov 21, 2025 08:01AM
Nov 21, 2025 08:01AM
Nov 13, 2025 01:51PM
Oct 15, 2025 07:14AM
Oct 15, 2025 07:14AM
Oct 9, 2025 07:05AM
Oct 9, 2025 07:04AM 60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study
Oct 2, 2025 09:00AM
Aug 19, 2025 08:54AM
Aug 19, 2025 08:54AM
Aug 13, 2025 04:14PM
Jul 17, 2025 08:01AM
Jul 17, 2025 08:01AM
Jul 16, 2025 04:01PM 60 Degrees Pharmaceuticals closes $5 million public offering
Jul 16, 2025 04:01PM
Jul 15, 2025 09:10AM
Jul 15, 2025 09:10AM
Jul 15, 2025 07:02AM
Jul 15, 2025 07:01AM
Jul 14, 2025 04:01PM
Jul 14, 2025 04:01PM 60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025
Jun 4, 2025 08:57AM

325,297 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All